ERBB2 and malignant colon neoplasm: In order to achieve this purpose, Dharmapuri et al. used electroporation, introducing DNA for CEA- and HER2-positive colon cancer, and used TLR7 agonists to induce IFNα to enhance the overall efficacy [31].